HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fastenau, D. R. Articles by McIntyre, J. A. Search for Related Content PubMed PubMed Citation Articles by Fastenau, D. R. Articles by McIntyre, J. A.

Ann Thorac Surg 1999;68:137-142
© 1999 The Society of Thoracic Surgeons

---

Original Articles

Increased incidence of antiphospholipid antibodies in left ventricular assist system recipients

^a Center for Reproduction and Transplantation Immunology, Methodist Hospital, Indianapolis, Indiana, USA

Address reprint requests to Dr McIntyre, Center for Reproduction and Transplantation Immunology, Methodist Hospital of Indiana, 1701 N Senate Blvd, Indianapolis, IN 46202
e-mail: jmcintyre{at}clarian.com

Background. Antiphospholipid antibodies are associated with thrombosis. Because thromboembolic complications are often observed in recipients of a left ventricular assist system, we questioned if antiphospholipid antibodies were present in these patients. We report results from 10 patients who received a Novacor left ventricular assist system.

Methods. Serum samples were collected before left ventricular assist system placement and weekly thereafter until discharge after cardiac transplantation. Samples were tested for IgG, IgA, and IgM antiphosphatidylserine, anticardiolipin, and antiphosphatidylethanolamine using an enzyme-linked immunosorbent assay.

Results. Development of phospholipid-binding plasma protein–dependent antiphospholipid antibodies was observed in 9 of the 10 patients. Before placement of the assist system, 3 patients had IgG antiphospholipid antibodies, and 9 were positive after placement. None had IgA antiphospholipid antibodies before placement, whereas 5 seroconverted for IgA after placement. One patient had IgM antiphospholipid antibodies before placement, and 1 additional patient became positive after placement. In patients with a preexisting antibody, increased titers and additional specificities developed subsequent to placement.

Conclusions. All but 1 patient showed development of phospholipid-binding plasma protein–dependent antiphospholipid antibodies after left ventricular assist system placement.

This article has been cited by other articles:

				D. R. Fastenau and J. A. McIntyre Immunochemical analysis of polyspecific antibodies in patients exposed to bovine fibrin sealant Ann. Thorac. Surg., June 1, 2000; 69(6): 1867 - 1872. [Abstract] [Full Text] [PDF]